Dietary Proteins
Methodology & AI Transparency ⓘ
Dietary Proteins Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Protein is in every cell in the body.
- 2 Real-world patient consensus: Federal ICD-10-CM code L30.1 categorizes Dietary Proteins under Dermatology: Acne, Eczema, Psoriasis & Rosacea.
- 3 Typical cash cost range: Differential triage of Dietary Proteins (L30.1) utilizes or targeted biologics [Dietary Proteins L30.1].
- 4 Top reported side effects / signs: Key Skin & Dermatology biomarkers for Dietary Proteins (L30.1): Affected Body Surface in Dietary Proteins (L30.1: Area (BSA /) & Fasting Lipids & in Dietary Proteins (L30.1: ALT (if systemic) (Within baseline reference limits (L30.1)).
Ask our AI Specialists anything about Dietary Proteins
What Is Dietary Proteins?
Protein is in every cell in the body. Our bodies need protein from the foods we eat to build and maintain bones, muscles and skin. We get proteins in our diet from meat, dairy products, nuts, and certain grains and beans. Proteins from meat and other animal products are complete proteins. This means they supply all of the amino acids the body can't make on its own. Most plant proteins are incomplete. You should eat different types of plant proteins every day to get all of the amino acids your body needs. It is important to get enough dietary protein. You need to eat protein every day, because your body doesn't store it the way it stores fats or carbohydrates.
Pathophysiology, Underlying Causes & Clinical Presentation
Dietary Proteins (L30.1) alters skin & dermatology homeostasis through epidermal barrier filaggrin/ceramide in Dietary Proteins (L30.1: disruption); Cross-referenced with NIH MeSH (Dietary Proteins), clinical remission targets Fasting Lipids & in Dietary Proteins (L30.1: ALT (if systemic) within Within baseline reference limits (L30.1).
Common Symptoms & Clinical Signs
- • Presentation of Dietary Proteins (L30.1): persistent erythematous plaques, in Dietary Proteins (L30.1: scaly patches, pruritic)
- • Secondary Dietary Proteins clinical sign: compromised epidermal barrier in Dietary Proteins (L30.1: with dryness, fissuring,)
- • Symptom flares in Dietary Proteins correlating with Affected Body Surface in Dietary Proteins (L30.1: Area (BSA /) deviation outside Clear or Almost Clear (IGA 0–1) (L30.1)
- • Functional skin & dermatology impact requiring or targeted biologics [Dietary Proteins L30.1] evaluation (L30.1)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Dietary Proteins Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | L30.1 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Dermatology: Acne, Eczema, Psoriasis & Rosacea | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Affected Body Surface in Dietary Proteins (L30.1: Area (BSA /) | Clear or Almost Clear (IGA 0–1) (L30.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Fasting Lipids & in Dietary Proteins (L30.1: ALT (if systemic) | Within baseline reference limits (L30.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: 25-Hydroxy Vitamin D in Dietary Proteins (L30.1: & hs-CRP) | 25(OH)D 40–65 ng/mL (L30.1) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Dietary Proteins
Treatment selection for Dietary Proteins depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Dietary Proteins)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Phase III study to compare real-world benefits and safety of BAT2206 (proposed: What a 278-Participant Study Found BAT2206 and UST were comparable in terms of efficacy, safety, how the body absorbs the medicine, and immunogenicity. Journal of the American Academy of Dermatology • 2025-04-15 • Phase III Randomized Trial | N = 278 | 93/100 | PMID 39592058 ↗ |
| New Insights on Dietary Nutrient Intake and Progression to Late Age-Related Macular Degeneration: What a 4,504-Participant Study Found Higher dietary intake of multiple nutrients, including minerals, vitamins, and carotenoids, is associated with decreased risk of progression to late AMD. Ophthalmology • 2021-03-15 • Phase III Randomized Trial | N = 4,504 | 90/100 | PMID 32858063 ↗ |
| Can This Approach Help? Inside the Latest Research on Effects of the Dietary Supplement Trans-resveratrol on Heme Oxygenase-1 (HO-1) Heme oxygenase 1 (HO-1) serves as a protective gene. The aim of this clinical trial is to evaluate the HO-1 stimulation of resveratrol in healthy humans. ClinicalTrials.gov Registry (NIH NLM) • 2011-03-01 • Completed Human Clinical Trial (NCT) | N = 10 | 89/100 | PMID NCT01768507 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of tildrakizumab for the treatment of moderate-to-severe Real-world benefits and safety of tildrakizumab for the treatment of scalp psoriasis are sustained long-term. Journal of the American Academy of Dermatology • 2025-04-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 39722400 ↗ |
| Can This Approach Help? Inside the Latest Research on Is dietary melatonin supplementation a viable add-on treatment for chronic Daily dietary 10 mg of melatonin supplementation might serve as a viable adjunct to SRP that yielded significantly greater CAL gain and PD reduction and lower salivary TNF-α levels and AIS scores in gCP patients with primary... Journal of periodontal research • 2019-04-15 • Randomized Controlled Trial | N = 38 | 88/100 | PMID 30298556 ↗ |
Dietary Proteins Patient Community & “People Like Me” Threads
Filter Dietary Proteins community threads and patient logs by age, biological sex, dosage, and treatment duration.